These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10412790)

  • 21. Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients.
    Ikejiri A; Hirano T; Murayama S; Yoshino G; Gushiken N; Hyodo T; Taira T; Adachi M
    Metabolism; 2004 Sep; 53(9):1113-7. PubMed ID: 15334369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
    Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H
    Atherosclerosis; 1997 Jun; 131(2):229-36. PubMed ID: 9199276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormalities of composition and of in vitro lipolysis products of human small very low density lipoproteins in hypertriglyceridemia.
    Tornvall P; Hamsten A; Carlson LA
    Atherosclerosis; 1990 May; 82(1-2):125-35. PubMed ID: 2360914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.
    Siegel RD; Cupples A; Schaefer EJ; Wilson PW
    Metabolism; 1996 Oct; 45(10):1267-72. PubMed ID: 8843183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet.
    Fisher WR; Zech LA; Stacpoole PW
    J Lipid Res; 1998 Feb; 39(2):388-401. PubMed ID: 9507999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.
    Pontrelli L; Parris W; Adeli K; Cheung RC
    Metabolism; 2002 Mar; 51(3):334-42. PubMed ID: 11887170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
    Quaschning T; Krane V; Metzger T; Wanner C
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
    Granot E
    Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients.
    Hirano T; Yoshino G; Kashiwazaki K; Adachi M
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):908-13. PubMed ID: 11587157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of low molecular weight heparin compared to conventional heparin for anticoagulation during haemodialysis on low density lipoprotein subclasses.
    Wiemer J; Winkler K; Baumstark M; März W; Scherberich JE
    Nephrol Dial Transplant; 2002 Dec; 17(12):2231-8. PubMed ID: 12454238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
    Winocour PH; Durrington PN; Bhatagnar D; Ishola M; Mackness M; Arrol S; Anderson DC
    Atherosclerosis; 1992 Mar; 93(1-2):83-94. PubMed ID: 1596307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes.
    Howard BV; Abbott WG; Beltz WF; Harper IT; Fields RM; Grundy SM; Taskinen MR
    Metabolism; 1987 Sep; 36(9):870-7. PubMed ID: 3626866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The composition of low (LDL) and very low (VLDL) density lipoprotein subfractions in type III hyperlipoproteinaemia: comparison with normal subjects.
    Stromber P; Ballantyne D; Ballantyne FC; Third JL; Bedford DK
    Clin Chim Acta; 1977 Aug; 79(1):163-72. PubMed ID: 196790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertriglyceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles.
    Okazaki M; Usui S; Tokunaga K; Nakajima Y; Takeichi S; Nakano T; Nakajima K
    Clin Chim Acta; 2004 Jan; 339(1-2):169-81. PubMed ID: 14687907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.